Report date: Apr 30, 2024 Conflict count: 350192 Publisher: Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins Title count: 161 Conflict count: 5838 ========================================================== Created: 2019-04-23 11:44:54.0 ConfID: 5465881 CauseID: 1443612511 OtherID: 1339660014 JT: American Journal of Clinical Oncology MD: Arcangeli, 25 ,5,431,2002,Accelerated Hyperfractionated Radiotherapy and Concurrent Protracted Venous Infusion Chemotherapy in Locally Advanced Head and Neck Cancer : DOI: 10.1097/00000421-200210000-00001(Journal) (5465881-N ) DOI: 10.1097/01.COC.0000017638.92937.82(Journal) ========================================================== Created: 2019-04-23 11:44:54.0 ConfID: 5465882 CauseID: 1443612511 OtherID: 1339660014 JT: American Journal of Clinical Oncology MD: Swanson, 25 ,5,438,2002,Significance of Margins of Excision on Breast Cancer Recurrence : DOI: 10.1097/00000421-200210000-00002(Journal) (5465882-N ) DOI: 10.1097/01.COC.0000023419.23779.C7(Journal) ========================================================== Created: 2019-04-23 11:44:54.0 ConfID: 5465883 CauseID: 1443612511 OtherID: 1339660014 JT: American Journal of Clinical Oncology MD: Heron, 25 ,5,442,2002,Anaplastic Thyroid Carcinoma : Comparison of Conventional Radiotherapy and Hyperfractionation Chemoradiotherapy in Two Groups DOI: 10.1097/00000421-200210000-00003(Journal) (5465883-N ) DOI: 10.1097/01.COC.0000023060.34146.B3(Journal) ========================================================== Created: 2019-04-23 11:44:54.0 ConfID: 5465884 CauseID: 1443612511 OtherID: 1339660014 JT: American Journal of Clinical Oncology MD: Halperin, 25 ,5,535,2002,The Corporate Presence at Oncology Meetings : DOI: 10.1097/00000421-200210000-00023(Journal) (5465884-N ) DOI: 10.1097/01.COC.0000031461.61432.7A(Journal) ========================================================== Created: 2019-04-23 11:44:54.0 ConfID: 5465885 CauseID: 1443612511 OtherID: 1339660014 JT: American Journal of Clinical Oncology MD: Ring, 25 ,5,537,2002,Palliative Treatment: What’s the Point? : DOI: 10.1097/00000421-200210000-00024(Journal) (5465885-N ) DOI: 10.1097/01.COC.0000023420.56046.D3(Journal) ========================================================== Created: 2019-04-23 11:44:58.0 ConfID: 5465886 CauseID: 1443612518 OtherID: 1339660015 JT: American Journal of Clinical Oncology MD: Emrich, 25 ,6,541,2002,Radioiodinated (I-125) Monoclonal Antibody 425 in the Treatment of High Grade Glioma Patients : Ten-Year Synopsis of a Novel Treatment DOI: 10.1097/00000421-200212000-00001(Journal) (5465886-N ) DOI: 10.1097/01.COC.0000041009.06780.E5(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465887 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Bozkurt, 26 ,2,121,2003,Intrathoracic Extravasation of Antineoplastic Agents : Case Report and Systematic Review DOI: 10.1097/00000421-200304000-00003(Journal) (5465887-N ) DOI: 10.1097/01.COC.0000017088.74592.96(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465888 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Malik, 26 ,2,124,2003,Prospective Evaluation of Efficacy and Toxicity of 5-FU and Folinic Acid (Mayo Clinic Regimen) in Patients With Advanced Cancer of the Gallbladder : DOI: 10.1097/00000421-200304000-00004(Journal) (5465888-N ) DOI: 10.1097/01.COC.0000017090.36834.FE(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465889 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Gómez-Bernal, 26 ,2,127,2003,Biweekly Docetaxel and Vinorelbine in Anthracycline-Resistant Metastatic Breast Cancer : A Multicenter Phase II Study DOI: 10.1097/00000421-200304000-00005(Journal) (5465889-N ) DOI: 10.1097/01.COC.0000017091.69111.94(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465890 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Nasta, 26 ,2,132,2003,Phase II Study of MGI-114 Administered Intravenously for 5 Days Every 28 Days to Patients With Metastatic Colorectal Cancer : DOI: 10.1097/00000421-200304000-00006(Journal) (5465890-N ) DOI: 10.1097/01.COC.0000017092.65803.76(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465891 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Alexandrakis, 26 ,2,135,2003,Levels of Serum Cytokines and Acute Phase Proteins in Patients With Essential and Cancer-Related Thrombocytosis : DOI: 10.1097/00000421-200304000-00007(Journal) (5465891-N ) DOI: 10.1097/01.COC.0000017093.79897.DE(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465892 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Dillman, 26 ,2,141,2003,Does Continuous-Infusion Interleukin-2 Increase Survival in Metastatic Melanoma? : DOI: 10.1097/00000421-200304000-00008(Journal) (5465892-N ) DOI: 10.1097/01.COC.0000017094.76827.ED(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465893 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Landrum, 26 ,2,146,2003,Hypertrophic Osteoarthropathy Associated With Metastatic Phyllodes Tumor : DOI: 10.1097/00000421-200304000-00009(Journal) (5465893-N ) DOI: 10.1097/01.COC.0000017780.27940.F3(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465894 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Murad, 26 ,2,151,2003,Phase II Trial of the Use of Gemcitabine and 5-Fluorouracil in the Treatment of Advanced Pancreatic and Biliary Tract Cancer : DOI: 10.1097/00000421-200304000-00010(Journal) (5465894-N ) DOI: 10.1097/01.COC.0000017525.15572.52(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465895 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Mizowaki, 26 ,2,155,2003,Concurrent Chemotherapy and Radiotherapy With Low-Dose Cisplatin for Nasopharyngeal Carcinoma : DOI: 10.1097/00000421-200304000-00011(Journal) (5465895-N ) DOI: 10.1097/01.COC.0000018171.34854.08(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465896 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Furuse, 26 ,2,159,2003,Pilot Study of Transcatheter Arterial Chemoembolization with Degradable Starch Microspheres in Patients With Hepatocellular Carcinoma : DOI: 10.1097/00000421-200304000-00012(Journal) (5465896-N ) DOI: 10.1097/01.COC.0000018174.53573.67(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465897 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Lisenko, 26 ,2,165,2003,Leptomeningeal Carcinomatosis Originating from Gastric Cancer : Report of Eight Cases and Review of the Literature DOI: 10.1097/00000421-200304000-00013(Journal) (5465897-N ) DOI: 10.1097/01.COC.0000018175.95100.D1(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465898 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Mannel, 26 ,2,171,2003,Impact of Individual Physicians on Enrollment of Patients into Clinical Trials : DOI: 10.1097/00000421-200304000-00014(Journal) (5465898-N ) DOI: 10.1097/01.COC.0000017798.43288.7C(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465899 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Malik, 26 ,2,174,2003,Gemcitabine and Cisplatin Is a Highly Effective Combination Chemotherapy in Patients With Advanced Cancer of the Gallbladder : DOI: 10.1097/00000421-200304000-00015(Journal) (5465899-N ) DOI: 10.1097/01.COC.0000018037.59196.67(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465900 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: McFarland, 26 ,2,178,2003,Palliative Irradiation of the Spleen : DOI: 10.1097/00000421-200304000-00016(Journal) (5465900-N ) DOI: 10.1097/01.COC.0000017799.59129.7D(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465901 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Kuten, 26 ,2,184,2003,Neoadjuvant Radiotherapy Concurrent With Weekly Paclitaxel and Carboplatin and Followed by Surgery in Locally Advanced Non-Small-Cell Lung Cancer : DOI: 10.1097/00000421-200304000-00017(Journal) (5465901-N ) DOI: 10.1097/01.COC.0000018176.96244.78(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465902 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Foster, 26 ,2,188,2003,HER-2/neu Overexpression detected by Immunohistochemistry in Soft Tissue Sarcomas : DOI: 10.1097/00000421-200304000-00018(Journal) (5465902-N ) DOI: 10.1097/01.COC.0000018178.85123.51(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465903 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Mintzer, 26 ,2,192,2003,On the Need for Biopsy Confirmation at Suspected First Recurrence of Cancer : DOI: 10.1097/00000421-200304000-00019(Journal) (5465903-N ) DOI: 10.1097/01.COC.0000017781.08453.93(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465904 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Hsiung Stripp, 26 ,2,197,2003,Three Cases of Advanced Seminoma and Downʼs Syndrome : A Possible Association DOI: 10.1097/00000421-200304000-00020(Journal) (5465904-N ) DOI: 10.1097/01.COC.0000018298.72379.AC(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465905 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Hanna, 26 ,2,200,2003,Phase I Trial of Carboplatin and Paclitaxel With Escalating Doses of Oral Topotecan in Patients With Solid Tumors : DOI: 10.1097/00000421-200304000-00021(Journal) (5465905-N ) DOI: 10.1097/01.COC.0000017783.22855.4E(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465906 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Sohn, 26 ,2,203,2003,Infusional Fluorouracil, Etoposide, and Cisplatin (FEP) in Advanced and Relapsed Gastric Cancer : DOI: 10.1097/00000421-200304000-00022(Journal) (5465906-N ) DOI: 10.1097/01.COC.0000017800.63585.37(Journal) ========================================================== Created: 2019-04-23 11:45:03.0 ConfID: 5465907 CauseID: 1443612526 OtherID: 1339660013 JT: American Journal of Clinical Oncology MD: Kang, 26 ,2,210,2003,Low-Dose Radiation for Posttransplant Lymphoproliferative Disorder : DOI: 10.1097/00000421-200304000-00023(Journal) (5465907-N ) DOI: 10.1097/01.COC.0000020580.59825.75(Journal) ========================================================== Created: 2021-05-09 17:15:45.0 ConfID: 6033433 CauseID: 1498109356 OtherID: 257590597 JT: American Journal of Clinical Oncology MD: Fishman, 29 ,3,225,2006,Natural History and Chemotherapy Effectiveness for Advanced Adenocarcinoma of the Small Bowel: A Retrospective Review of 113 Cases DOI: 10.1097/01. coc.0000214931.01062.01(Journal) (6033433-N ) DOI: 10.1097/01.coc.0000214931.01062.01(Journal)